JP2016522406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016522406A5 JP2016522406A5 JP2016513253A JP2016513253A JP2016522406A5 JP 2016522406 A5 JP2016522406 A5 JP 2016522406A5 JP 2016513253 A JP2016513253 A JP 2016513253A JP 2016513253 A JP2016513253 A JP 2016513253A JP 2016522406 A5 JP2016522406 A5 JP 2016522406A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- subject
- pick disease
- level
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020019691A JP6989636B2 (ja) | 2013-05-14 | 2020-02-07 | ニーマン・ピック病の診断のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13002515.8 | 2013-05-14 | ||
| EP13002515 | 2013-05-14 | ||
| PCT/EP2014/001306 WO2014183873A1 (en) | 2013-05-14 | 2014-05-14 | Method for the diagnosis of niemann-pick disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020019691A Division JP6989636B2 (ja) | 2013-05-14 | 2020-02-07 | ニーマン・ピック病の診断のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016522406A JP2016522406A (ja) | 2016-07-28 |
| JP2016522406A5 true JP2016522406A5 (enExample) | 2017-06-08 |
| JP6660291B2 JP6660291B2 (ja) | 2020-03-11 |
Family
ID=48428310
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513253A Expired - Fee Related JP6660291B2 (ja) | 2013-05-14 | 2014-05-14 | ニーマン・ピック病の診断のための方法 |
| JP2020019691A Expired - Fee Related JP6989636B2 (ja) | 2013-05-14 | 2020-02-07 | ニーマン・ピック病の診断のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020019691A Expired - Fee Related JP6989636B2 (ja) | 2013-05-14 | 2020-02-07 | ニーマン・ピック病の診断のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10302664B2 (enExample) |
| EP (1) | EP2997384B1 (enExample) |
| JP (2) | JP6660291B2 (enExample) |
| CA (1) | CA2912274A1 (enExample) |
| CY (1) | CY1121790T1 (enExample) |
| DK (1) | DK2997384T3 (enExample) |
| ES (1) | ES2731920T3 (enExample) |
| SA (1) | SA515370129B1 (enExample) |
| TR (1) | TR201906195T4 (enExample) |
| WO (1) | WO2014183873A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102292298B1 (ko) * | 2013-06-07 | 2021-08-24 | 젠자임 코포레이션 | 산 스핑고미엘리나제 장애에 대한 마커 및 이의 용도 |
| AU2015349030A1 (en) * | 2014-11-19 | 2017-05-04 | Centogene Gmbh | Method for the diagnosis of Niemann-Pick disease using a biomarker |
| CN119861166A (zh) * | 2019-05-31 | 2025-04-22 | 建新公司 | 二维lc-ms/ms系统 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9908190D0 (en) * | 1999-04-09 | 1999-06-02 | Pharming Intellectual Pty Bv | Diagnosis of lysosomal storage disorders using saposins and other markers |
| GB0128498D0 (en) * | 2001-11-28 | 2002-01-23 | Inst Of Child Health | International standards for sphingolipids |
| US8173443B2 (en) * | 2003-03-31 | 2012-05-08 | Women's And Children's Hospital | Multiplex screening for lysosomal storage disorders (LSDs) |
| US7750050B2 (en) * | 2003-11-25 | 2010-07-06 | Mount Sinai School Of Medicine Of New York University | Chaperone-based therapy for Niemann-Pick disease |
| WO2007109881A1 (en) * | 2006-03-24 | 2007-10-04 | Phenomenome Discoveries Inc. | Biomarkers useful for diagnosing prostate cancer, and methods thereof |
| US8497122B2 (en) * | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
| US8313949B2 (en) * | 2009-04-16 | 2012-11-20 | Nextcea Inc. | Detecting phospholipidosis and diagnosing lysosomal storage disorders |
| KR20200034828A (ko) * | 2009-08-28 | 2020-03-31 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 산성 스핑고미엘리나제 결핍을 치료하기 위한 투여량 단계적 증가 효소 대체 요법 |
-
2014
- 2014-05-14 JP JP2016513253A patent/JP6660291B2/ja not_active Expired - Fee Related
- 2014-05-14 US US14/890,969 patent/US10302664B2/en not_active Expired - Fee Related
- 2014-05-14 CA CA2912274A patent/CA2912274A1/en not_active Abandoned
- 2014-05-14 DK DK14724315.8T patent/DK2997384T3/da active
- 2014-05-14 WO PCT/EP2014/001306 patent/WO2014183873A1/en not_active Ceased
- 2014-05-14 ES ES14724315T patent/ES2731920T3/es active Active
- 2014-05-14 EP EP14724315.8A patent/EP2997384B1/en active Active
- 2014-05-14 TR TR2019/06195T patent/TR201906195T4/tr unknown
-
2015
- 2015-11-11 SA SA515370129A patent/SA515370129B1/ar unknown
-
2019
- 2019-07-03 CY CY20191100702T patent/CY1121790T1/el unknown
-
2020
- 2020-02-07 JP JP2020019691A patent/JP6989636B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6954839B2 (ja) | アルツハイマー病の診断及び治療のための材料及び方法 | |
| JP2014533367A5 (enExample) | ||
| JP6678046B2 (ja) | 質量分析によるサイログロブリン定量 | |
| Al Awam et al. | Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia | |
| Du et al. | Complete identification of all 20 relevant epimeric peptides in β-amyloid: a new HPLC-MS based analytical strategy for Alzheimer's research | |
| JP2022071119A (ja) | 肺癌を検出するためのバイオマーカーパネル | |
| WO2020117849A1 (en) | Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring | |
| CN102348982B (zh) | 肌变性疾病的检测方法以及治疗效果判定方法 | |
| Lukic et al. | An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis | |
| JP2016522406A5 (enExample) | ||
| Calvano et al. | Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles | |
| WO2018007422A1 (en) | Identification of human non-alcoholic fatty liver disease (nafld) subtypes | |
| CN113164627A (zh) | 治疗和监测颗粒体蛋白前体相关病症的方法 | |
| JP2025172848A (ja) | マススペクトロメトリーによるアポリポタンパク質ｅアイソタイプの検出 | |
| JP2020064051A (ja) | 神経変性疾患の診断用ペプチドマーカー | |
| US20140162903A1 (en) | Metabolite Biomarkers For Forecasting The Outcome of Preoperative Chemotherapy For Breast Cancer Treatment | |
| US20180275151A1 (en) | Metabolomic signature of diagnosis and disease progression in non-alcoholic fatty liver disease (nafld) | |
| Liu et al. | Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer | |
| ES2839514T3 (es) | Métodos de diagnóstico basados en perfiles de lípidos | |
| WO2021222109A1 (en) | Methods of detecting ube3a protein | |
| JP7678483B2 (ja) | コロナウイルス感染を検出する方法 | |
| CN112599240B (zh) | 代谢物在脑梗死中的应用 | |
| Gervasoni et al. | Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects | |
| JP2024117521A (ja) | 膵臓がんの検出方法 | |
| JP5147684B2 (ja) | アルツハイマー病の診断のためのポリペプチドマーカー |